| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...746667K |
| P356 | DOI | 10.1371/JOURNAL.PONE.0046667 |
| P932 | PMC publication ID | 3468630 |
| P698 | PubMed publication ID | 23071609 |
| P5875 | ResearchGate publication ID | 232257241 |
| P50 | author | Jürgen Schneider-Schaulies | Q88587804 |
| P2093 | author name string | Tobias Abel | |
| Christian J Buchholz | |||
| Sabrina Kneissl | |||
| Julia Brynza | |||
| Anke Rasbach | |||
| P2860 | cites work | Adherens junction protein nectin-4 is the epithelial receptor for measles virus | Q24295305 |
| Crystal structure of measles virus hemagglutinin provides insight into effective vaccines | Q24669991 | ||
| Structure of the measles virus hemagglutinin bound to the CD46 receptor | Q27658662 | ||
| Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo | Q29616612 | ||
| Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization | Q33930445 | ||
| Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus | Q34013640 | ||
| Antibodies to a new linear site at the topographical or functional interface between the haemagglutinin and fusion proteins protect against measles encephalitis. | Q52895150 | ||
| Rescue and propagation of fully retargeted oncolytic measles viruses | Q81348398 | ||
| Gene delivery by lentivirus vectors | Q34688367 | ||
| DARPins: an efficient targeting domain for lentiviral vectors | Q34757199 | ||
| Lentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cells. | Q36220659 | ||
| Engineering targeted viral vectors for gene therapy | Q36868494 | ||
| Lentiviral vectors with measles virus glycoproteins - dream team for gene transfer? | Q37425507 | ||
| Targeted cell entry of lentiviral vectors | Q37589994 | ||
| Ex vivo gene transfer and correction for cell-based therapies | Q37858878 | ||
| Recombinant measles viruses expressing altered hemagglutinin (H) genes: functional separation of mutations determining H antibody escape from neurovirulence | Q39606516 | ||
| Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors. | Q39814405 | ||
| Pseudotyping lentiviral vectors with the wild-type measles virus glycoproteins improves titer and selectivity | Q39884626 | ||
| Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins. | Q39936642 | ||
| Antigenic determinants of measles virus hemagglutinin associated with neurovirulence. | Q40039438 | ||
| Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies | Q41162662 | ||
| Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors | Q42863043 | ||
| Immunodominant domains of the Measles virus hemagglutinin protein eliciting a neutralizing human B cell response | Q45710647 | ||
| High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter | Q45732758 | ||
| Targeted lentiviral vectors pseudotyped with the Tupaia paramyxovirus glycoproteins | Q45876186 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| measles | Q79793 | ||
| vector-borne disease | Q2083837 | ||
| P304 | page(s) | e46667 | |
| P577 | publication date | 2012-10-10 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies | |
| P478 | volume | 7 |
| Q59356321 | A simple strategy for retargeting lentiviral vectors to desired cell types via a disulfide-bond-forming protein-peptide pair |
| Q34010344 | Antibody neutralization of retargeted measles viruses |
| Q38073294 | Biosafety features of lentiviral vectors |
| Q41899254 | CD105 is a surface marker for receptor-targeted gene transfer into human long-term repopulating hematopoietic stem cells |
| Q35238704 | CD133-targeted gene transfer into long-term repopulating hematopoietic stem cells |
| Q42254939 | CD19 and CD20 targeted vectors induce minimal activation of resting B lymphocytes |
| Q37483972 | Deregulation of DUX4 and ERG in acute lymphoblastic leukemia |
| Q40211579 | Immune Modulatory Cell Therapy for Hemophilia B Based on CD20-Targeted Lentiviral Gene Transfer to Primary B Cells. |
| Q36047074 | Receptor-Targeted Nipah Virus Glycoproteins Improve Cell-Type Selective Gene Delivery and Reveal a Preference for Membrane-Proximal Cell Attachment |
| Q45875762 | Retargeting Lentiviruses via SpyCatcher-SpyTag Chemistry for Gene Delivery into Specific Cell Types |
| Q36827199 | The receptor attachment function of measles virus hemagglutinin can be replaced with an autonomous protein that binds Her2/neu while maintaining its fusion-helper function |
| Q99237801 | Use of Cell and Genome Modification Technologies to Generate Improved "Off-the-Shelf" CAR T and CAR NK Cells |
Search more.